Godrej Agrovet
Other · 2 quarters tracked · source-linked performance and management context.
Latest revenue
₹2,333 Cr
verified financial record
Quarters tracked
2
source records in the directory
Delivery assessment
0
Across 1 tracked commitments: 0 delivered, 1 missed.
Call date
2026-05-15
latest available source date
Signal trajectory
1 actual quarterCurrent read
0/100
Across 1 tracked commitments: 0 delivered, 1 missed.
Latest source read
What changed this quarter?
Godrej Agrovet delivered a strong Q4 FY26 with consolidated revenue of ₹2,333 crore (+9% YoY) and PBT growth of 16.8% to ₹87 crore. Full-year revenue crossed ₹10,000 crore milestone at ₹10,233 crore (+9% YoY), with PBT up 17.2% to ₹569 crore. Performance was driven by volume-led growth in animal nutrition (cattle feed volumes +24%), record oil palm area expansion and extraction ratio improvement, and Aztec Life Sciences turning EBITDA positive. Management guided for early double-digit revenue growth and mid-teens PBT growth in FY27, with capex of ~₹350-400 crore and free cash flow of ₹100-125 crore. Key risks include potential El Niño impact on monsoons and Iran war uncertainty affecting palm oil prices and crop protection demand.
Colored figures compare against the previous available record. Hover or focus one for the comparison.
Signal
Positive
Revenue
₹2,333 Cr
Source date
2026-05-15
Across the record
Quarter history.
History modules